Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Vancomycin

🥰Excellent
Hot
Catalog No. T8641Cas No. 1404-90-6

Vancomycin is a glycopeptide antibiotic that exerts its antibacterial activity by inhibiting the second stage of cell wall synthesis in susceptible bacteria. It also alters cell membrane permeability and selectively inhibits RNA synthesis. Vancomycin is commonly used to treat severe infections resistant to other antibiotics and is frequently employed in experimental studies to induce kidney injury models.

Vancomycin

Vancomycin

🥰Excellent
Hot
Purity: 99.52%
Catalog No. T8641Cas No. 1404-90-6
Vancomycin is a glycopeptide antibiotic that exerts its antibacterial activity by inhibiting the second stage of cell wall synthesis in susceptible bacteria. It also alters cell membrane permeability and selectively inhibits RNA synthesis. Vancomycin is commonly used to treat severe infections resistant to other antibiotics and is frequently employed in experimental studies to induce kidney injury models.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
10 mg$30In StockIn Stock
25 mg$42In StockIn Stock
50 mg$66In StockIn Stock
100 mg$98In StockIn Stock
500 mg$212In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.52%
Appearance:Solid
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Vancomycin is a glycopeptide antibiotic that exerts its antibacterial activity by inhibiting the second stage of cell wall synthesis in susceptible bacteria. It also alters cell membrane permeability and selectively inhibits RNA synthesis. Vancomycin is commonly used to treat severe infections resistant to other antibiotics and is frequently employed in experimental studies to induce kidney injury models.
Targets&IC50
L1210 cells:> 1000 μg/mL, L02 cells:> 30 μM, HEK293 cells:> 100 μM (CC50)
In vitro
METHODS: B. burgdorferi was treated with Vancomycin (0.5-2.0 µg/mL) for 24 h and cell morphology was examined using real-time time-lapse microscopy.
RESULTS: At higher concentrations of Vancomycin (≥1.0 µg/mL), many abnormal cells were observed, which were visually identified by vesiculation, granule formation, and morphological changes. The proportion of these abnormal bacteria in the population increased in a dose-dependent manner. [1]
METHODS: Human osteosarcoma cells MG-63 were treated with Vancomycin (10-10000 µg/mL) for 24-72 h. Cell counts were measured using an Elzone Celi Counter.
RESULTS: Localized levels of Vancomycin at 1000 µg/mL and below had little effect on osteoblast replication, and concentrations of 10,000 µg/mL resulted in cell death. [2]
In vivo
METHODS: To detect nephrotoxicity, Vancomycin (400 mg/kg) and Vitamin C (200 mg/kg) were administered intraperitoneally to C57BL/6J mice once daily for seven days.
RESULTS: Renal index, renal injury score, apoptosis, serum Cr and BUN, as well as renal Cr, BUN, MDA, IL-1β, IL-6, TNF-α, and NF-κB were higher in the Vancomycin group than in the control group, whereas body weight and renal SOD activity were lower. On the contrary, no differences were observed between the control and Vitamin C groups in all these indices. [3]
METHODS: To deplete the intestinal microbiota of mice, the antibiotics (ABX) Vancomycin (0.5 g/L), Ampicillin (1 g/L), Neomycin sulfate (1 g/L), and metronidazole (1 g/L) were administered to mice by drinking water for two weeks.
RESULTS: Antibiotics significantly reduced the diversity and composition of the gut microbiota. [4]
Chemical Properties
Molecular Weight1449.25
FormulaC66H75Cl2N9O24
Cas No.1404-90-6
SmilesO(C=1C2=CC3=CC1OC=4C(Cl)=CC(=CC4)[C@@H](O)[C@@H](NC([C@@H](CC(C)C)NC)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@]3(C(=O)N[C@@]5(C=6C=C(C=7C([C@@H](C(O)=O)NC(=O)[C@]([C@H](O)C=8C=C(Cl)C(O2)=CC8)(NC5=O)[H])=CC(O)=CC7O)C(O)=CC6)[H])[H])[C@H]9[C@H](O[C@H]%10C[C@](C)(N)[C@H](O)[C@H](C)O%10)[C@@H](O)[C@H](O)[C@@H](CO)O9
Relative Density.1.65 g/cm3
Sequence{d-Leu}-{d-Tyr}-Asn-{d-Nty}-{d-Nty}-Tyr-{Nty} (Covalent bridge:Tyr2-Nty4, Nty4-Tyr6, Nty5-Nty7)
Sequence Short{d-Leu}-{d-Tyr}-N-{d-Nty}-{d-Nty}-Y-{Nty} (Covalent bridge:Tyr2-Nty4, Nty4-Tyr6, Nty5-Nty7)
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 250 mg/mL (172.5 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Saline: 1 mg/mL (0.69 mM), Solution.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM0.6900 mL3.4501 mL6.9001 mL34.5006 mL
5 mM0.1380 mL0.6900 mL1.3800 mL6.9001 mL
10 mM0.0690 mL0.3450 mL0.6900 mL3.4501 mL
20 mM0.0345 mL0.1725 mL0.3450 mL1.7250 mL
50 mM0.0138 mL0.0690 mL0.1380 mL0.6900 mL
100 mM0.0069 mL0.0345 mL0.0690 mL0.3450 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Vancomycin | purchase Vancomycin | Vancomycin cost | order Vancomycin | Vancomycin chemical structure | Vancomycin in vivo | Vancomycin in vitro | Vancomycin formula | Vancomycin molecular weight